IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors

Vaccine

Volumn 24, Issue 9, 2006, Pages 1451-1461

  Klas, Sheri D ^a   Lavine, Christy L ^a   Whitt, Michael A ^a,b   Miller, Mark A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GTx Inc   (United States)

Author keywords

IL 12; Rodent; Vaccination

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; INTERLEUKIN 12; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; DRUG POTENCY; FEMALE; GENETIC PROCEDURES; HOST CELL; IMMUNIZATION; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CELLS, CULTURED; FEMALE; GENETIC VECTORS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; RECOMBINANT FUSION PROTEINS; SPLEEN; VACCINATION; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 32344448460     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.05.046     Document Type: Article

References (69)

1. L.C. Afonso, T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott The adjuvant effect of interleukin-12 in a vaccine against Leishmania major Science 263 5144 1994 235 237
2. J. Bliss, V. Van Cleave, K. Murray, A. Wiencis, M. Ketchum, and R. Maylor IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response J Immunol 156 3 1996 887 894
3. M.A. Miller, M.J. Skeen, and H.K. Ziegler Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes J Immunol 155 1995 4817 4828
4. M.A. Miller, M.J. Skeen, and H.K. Ziegler A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes J Immunol (Cutting Edge) 159 8 1997 3675 3679
5. M.A. Miller, M.J. Skeen, and H.K. Ziegler Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12 Cell Immunol 184 2 1998 92 104
6. D.H. Barouch, A. Craiu, M.J. Kuroda, J.E. Schmitz, X.X. Zheng, and S. Santra Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys Proc Natl Acad Sci USA 97 8 2000 4192 4197
7. J.D. Boyer, A.D. Cohen, K.E. Ugen, R.L. Edgeworth, M. Bennett, and A. Shah Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids Aids 14 11 2000 1515 1522
8. A. D'Andrea, M. Rengaraju, N.M. Valiante, J. Chehimi, M. Kubin, and M. Aste Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells J Exp Med 176 5 1992 1387 1398
9. S.E. Macatonia, N.A. Hosken, M. Litton, P. Vieira, C.S. Hsieh, and J.A. Culpepper Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells J Immunol 154 10 1995 5071 5079
10. G. Trinchieri Interleukin-12 and its role in the generation of TH1 cells Immunol Today 14 7 1993 335 338
11. + T cells through IL-12 produced by Listeria-induced macrophages Science 260 5107 1993 547 549
12. S. Rossol, G. Marinos, P. Carucci, M.V. Singer, R. Williams, and N.V. Naoumov Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B J Clin Invest 99 12 1997 3025 3033
13. J.S. Orange, and C.A. Biron Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection J Immunol 156 12 1996 4746 4756
14. J.A. Carr, J. Rogerson, M.J. Mulqueen, N.A. Roberts, and R.F. Booth Interleukin-12 exhibits potent antiviral activity in experimental herpes virus infections J Virol 71 10 1997 7799 7803
15. J.P. Sypek, C.L. Chung, S.E. Mayor, J.M. Subramanyam, S.J. Goldman, and D.S. Sieburth Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response J Exp Med 177 6 1993 1797 1802
16. P. Zhou, M.C. Sieve, J. Bennett, K.J. Kwon-Chung, R.P. Tewari, and R.T. Gazzinelli IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma J Immunol 155 2 1995 785 795
17. J.F. Urban Jr., R. Fayer, S.J. Chen, W.C. Gause, M.K. Gately, and F.D. Finkelman IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum J Immunol 156 1 1996 263 268
18. I. Narvaiza, G. Mazzolini, M. Barajas, M. Duarte, M. Zaratiegui, and C. Qian Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy J Immunol 164 6 2000 3112 3122
19. C.R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E.E. Sercarz, and F.L. Graham A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice J Immunol 162 2 1999 753 760
20. S.D. Klas, C.S. Robison, M.A. Whitt, and M.A. Miller Adjuvanticity of an IL-12 fusion protein expressed by recombinant DeltaG-vesicular stomatitis virus Cell Immunol 218 1-2 2002 59 73
21. T.A. Wynn, A. Reynolds, S. James, A.W. Cheever, P. Caspar, and S. Hieny IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite J Immunol 157 9 1996 4068 4078
22. D. Weiner Plasmid interleukin 12 Aids 14 12 2000 1759 1760
23. S.S. Ahuja, R.L. Reddick, N. Sato, E. Montalbo, V. Kostecki, and W. Zhao Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection J Immunol 163 7 1999 3890 3897
24. L. Zitvogel, B. Couderc, J.I. Mayordomo, P.D. Robbins, M.T. Lotze, and W.J. Storkus IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo Ann NY Acad Sci 795 1996 284 293 (Oct 31)
25. M.M. Gherardi, J.C. Ramirez, D. Rodriguez, J.R. Rodriguez, G. Sano, and F. Zavala IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner J Immunol 162 11 1999 6724 6733
26. E.E. Voest, B.M. Kenyon, M.S. O'Reilly, G. Truitt, R.J. D'Amato, and J. Folkman Inhibition of angiogenesis in vivo by interleukin 12 J Natl Cancer Inst 87 8 1995 581 586
27. B.D. Car, V.M. Eng, J.M. Lipman, and T.D. Anderson The toxicology of interleukin-12: a review Toxicol Pathol 27 1 1999 58 63
28. G.B. Mackaness Cellular resistance to infection J Exp Med 116 1962 381 406
29. S.H. Kaufmann Immunity to intracellular bacteria Annu Rev Immunol 11 1993 129 163
30. S.H. Gregory, L.K. Barczynski, and E.J. Wing Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections J Leukoc Biol 51 4 1992 421 424
31. R.D. Wagner, H. Steinberg, J.F. Brown, and C.J. Czuprynski Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection Microb Pathog 17 3 1994 175 186
32. A.M. Krieg, L. Love-Homan, A.K. Yi, and J.T. Harty CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge J Immunol 161 5 1998 2428 2434
33. T. Miura, T. Kudo, A. Matsuki, K. Sekikawa, Y. Tagawa, and Y. Iwakura Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection Infect Immun 69 12 2001 7234 7241
34. C.H. von Koenig, H. Finger, and H. Hof Failure of killed Listeria monocytogenes vaccine to produce protective immunity Nature 297 5863 1982 233 234
35. P. Berche, J.L. Gaillard, and P.J. Sansonetti Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity J Immunol 138 7 1987 2266 2271
36. M.A. Miller, M.J. Skeen, C.L. Lavine, and H. Kirk Ziegler IL-12-assisted immunization generates CD4+ T cell-mediated immunity to Listeria monocytogenes Cell Immunol 222 1 2003 1 14
37. M.J. Schnell, L. Buonocore, M.A. Whitt, and J.K. Rose The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus J Virol 70 4 1996 2318 2323
38. M.A. Miller, C.L. Lavine, S.D. Klas, L.M. Pfeffer, and M.A. Whitt Recombinant replication-restricted VSV as an expression system for bioactive murine cytokines Protein Exp. Purif. 33 1 2004 92 103
39. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, and S.M. Donahoe An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 5 2001 539 549
40. N.F. Rose, A. Roberts, L. Buonocore, and J.K. Rose Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1 J Virol 74 23 2000 10903 10910
41. E.A. Stillman, J.K. Rose, and M.A. Whitt Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins J Virol 69 5 1995 2946 2953
42. A. Takada, C. Robison, H. Goto, A. Sanchez, K.G. Murti, and M.A. Whitt A system for functional analysis of Ebola virus glycoprotein Proc Natl Acad Sci USA 94 26 1997 14764 14769
43. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 2 1991 193 199
44. G.J. Lieschke, P.K. Rao, M.K. Gately, and R.C. Mulligan Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo Nat Biotechnol 15 1 1997 35 40
45. C.S. Robison, and M.A. Whitt The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly J Virol 74 5 2000 2239 2246
46. J.E. Coligan, A.M. Kruisbeek, D.M. Margulies, E.M. Shevach, and W. Strober Current protocols in immunology 1991 John Wiley & Sons New York
47. P.A. Wentworth, and H.K. Ziegler The antigenic and mitogenic response of murine T and B lymphocytes to soluble proteins of Listeria monocytogenes J Immunol 138 8 1987 2671 2678
48. H.K. Ziegler, C.A. Orlin, and C.W. Cluff Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages Eur J Immunol 17 9 1987 1287 1296
49. H. Karasuyama, and F. Melchers Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors Eur J Immunol 18 1 1988 97 104
50. H.C. Cherwinski, J.H. Schumacher, K.D. Brown, and T.R. Mosmann Two types of mouse helper T cell clone. 3. Further differences in lymphokine synthesis between TH1 and TH2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies J Exp Med 166 1987 1229 1244
51. D.H. Barouch, A. Craiu, S. Santra, M.A. Egan, J.E. Schmitz, and M.J. Kuroda Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys J Virol 75 5 2001 2462 2467
52. D.B. Weiner, and R.C. Kennedy Genetic vaccines Sci Am 281 1 1999 50 57
53. H.L. Robinson DNA vaccines for immunodeficiency viruses Aids 11 Suppl. A 1997 S109 S119
54. T. Yoshida, K. Okuda, K.Q. Xin, K. Tadokoro, J. Fukushima, and S. Toda Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols Clin Exp Immunol 124 3 2001 445 452
55. K.Q. Xin, M. Urabe, J. Yang, K. Nomiyama, H. Mizukami, and K. Hamajima A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus Hum Gene Ther 12 9 2001 1047 1061
56. J.P. McGettigan, S. Sarma, J.M. Orenstein, R.J. Pomerantz, and M.J. Schnell Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector J Virol 75 18 2001 8724 8732
57. K. Haglund, I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J.K. Rose High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses J Virol 76 6 2002 2730 2738
58. Y. Huang, G. Hajishengallis, and S.M. Michalek Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter Infect Immun 69 4 2001 2154 2161
59. J.E. Galen, and M.M. Levine Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol 9 8 2001 372 376
60. B.K. al-Ramadi, E. Adeghate, N. Mustafa, A.S. Ponery, and M.J. Fernandez-Cabezudo Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model Mol Immunol 38 12-13 2002 931 940
61. B. Schlereth, L. Buonocore, A. Tietz, V. Meulen Vt, J.K. Rose, and S. Niewiesk Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose J Gen Virol 84 Pt 8 2003 2145 2151
62. A. Roberts, E. Kretzschmar, A.S. Perkins, J. Forman, R. Price, and L. Buonocore Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge J Virol 72 6 1998 4704 4711
63. A. Roberts, L. Buonocore, R. Price, J. Forman, and J.K. Rose Attenuated vesicular stomatitis viruses as vaccine vectors J Virol 73 5 1999 3723 3732
64. H.J. Ezelle, D. Markovic, and G.N. Barber Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector J Virol 76 23 2002 12325 12334
65. M. Fernandez, M. Porosnicu, D. Markovic, and G.N. Barber Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease J Virol 76 2 2002 895 904
66. M. Obuchi, M. Fernandez, and G.N. Barber Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity J Virol 77 16 2003 8843 8856
67. J.U. Gutterman Cytokine therapeutics: lessons from interferon alpha Proc Natl Acad Sci USA 91 4 1994 1198 1205
68. J.L. Biber, S. Jabbour, R. Parihar, J. Dierksheide, Y. Hu, and H. Baumann Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma Cell Immunol 216 1-2 2002 31 42
69. R.A. Lang, D. Metcalf, R.A. Cuthbertson, I. Lyons, E. Stanley, and A. Kelso Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage Cell 51 4 1987 675 686